Viatris divested its women's healthcare, API, and OTC businesses, including multiple manufacturing sites and R&D labs. These complex separations create significant operational and IT challenges, including managing Transition Services Agreements (TSAs), data migration, and evaluating new standalone systems for the remaining business units.
Filing excerpt
In March 2024, the Company completed the divestiture of its women's healthcare business, primarily related to its oral and injectable contraceptives, to Insud Pharma, S.L...
What this signalsFilings often name leadership changes, deals and spending plans.
Competitors
Regions named
Competitors named
sec-10krestructuringChargeGet every 10-K signal for Viatris and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Viatris this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/a677ca41-ee02-403b-9133-4be41ae65a58 returns this record as JSON. POST /v1/companies/enrich returns every signal for viatris.com.
{
"signal_id": "a677ca41-ee02-403b-9133-4be41ae65a58",
"signal_type": "sec-10k",
"signal_subtype": "restructuringCharge",
"detected_at": "2026-03-03T06:02:41.098+00:00",
"company": {
"name": "Viatris",
"domain": "viatris.com"
},
"data": {
"detail": "Viatris divested its women's healthcare, API, and OTC businesses, including multiple manufacturing sites and R&D labs. These complex separations create significant operational and IT challenges, including managing Transition Services Agreements (TSAs), data migration, and evaluating new standalone systems for the remaining business units.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Viatris completed multiple major divestitures in 2024 to streamline its business.",
"excerpts": "In March 2024, the Company completed the divestiture of its women's healthcare business, primarily related to its oral and injectable contraceptives, to Insud Pharma, S.L...",
"relevance": 0.7,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1792044/000179204426000013/vtrs-20251231.htm",
"filing_date": "2026-02-26",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Vendor review likely",
"signal_category": "financial",
"regions_mentioned": [
"India",
"France",
"Italy",
"U.K."
],
"competitors_mentioned": [
"Insud Pharma, S.L.",
"Matrix Pharma Private Limited",
"Cooper Consumer Health",
"Theramex HQ UK Limited"
]
}
}
curl https://signals.autobound.ai/v1/signals/a677ca41-ee02-403b-9133-4be41ae65a58 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"viatris.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.